Side-Effect Management

Late Effects With Chronic GVHD in Children After Hematopoietic Cell Transplantation

By

Vicki Moore, PhD

Researchers sought to determine the effect of chronic graft-versus-host disease on late effects after HCT in pediatric cancer survivors.

A-Fib Linked to Worse Hospital Outcomes in Multiple Myeloma

In stratified analysis, odds of all-cause mortality, hospital stay of more than five days higher for MM patients not using anticoagulation.

Low Engagement Limits Feasibility of Web-Based Self-Management Program for Adolescents With Cancer

By

Vicki Moore, PhD

Researchers sought to determine the feasibility of a web-based self-management program for adolescents with cancer.

Essential Oils Show Promise for Some Symptoms of Infusion-Based Cancer Treatments

By

Vicki Moore, PhD

Researchers sought to determine the efficacy of essential oil use for relief of symptom burden in patients receiving infusion-based therapy for GI, neuroendocrine, or skin cancer.

Epigallocatechin-3-Gallate Prophylaxis Reduced Incidence, Severity of Radiation-Induced Dermatitis in Breast Cancer

By

Vicki Moore, PhD

Researchers sought to determine the efficacy of epigallocatechin-3-gallate prophylaxis in reducing incidence and severity of radiation-induced dermatitis in patients with breast cancer undergoing postoperative radiotherapy.

Experts Address Managing Cancer-Related Pain in Setting of Opioid Abuse, Misuse

Palliative and addiction medicine specialists provide consensus-based guidance for three common clinical scenarios.

PTCy With Tacrolimus Safe, Effective at Reducing GVHD in Older Patients With Hematologic Cancers

By

Jessica Nye, PhD

Researchers sought to determine the safety and efficacy of posttransplantation cyclophosphamide with tacrolimus as prophylaxis for GVHD in patients with hematologic cancer after allogeneic hematopoietic cell transplantation.

Abiraterone and Enzalutamide Raise Metabolic, Cardiovascular Adverse Event Risks

By

Natasha Persaud

A report in the Journal of the National Cancer Institute presents findings from the first assessment of the real-world safety of abiraterone and enzalutamide in a national sample of Medicare beneficiaries with advanced prostate cancer.

Age, Follow-Up Interval Associated With Risk of Breast Cancer-Related Lymphedema After Axillary Lymph Node Dissection

By

Vicki Moore, PhD

Researchers sought to identify factors that increase the risk of developing breast cancer-related lymphedema in patients who underwent axillary lymph node dissection.

Nurse Navigators Increase Geriatric and Toxicity Screening, Referrals to Supportive Services

By

Jessica Nye, PhD

A pilot study delegated screening assessments to nurse navigators to determine if such a program would increase referrals to supportive services for older older patients.